AFP and cholangiocarcinoma: Circulatory tumor markers including carcinoembryonic antigen (CEA) for CRLM, α-fetoprotein (AFP) for HCC, and carbohydrate antigen 19-9 (CA19-9) for PDAC and CCA were not elevated in 5/27 patients.